Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Bio-Techne (TECH) over the last 17 years, with Q4 2025 value amounting to -$500000.0.

  • Bio-Techne's Gains from Investment Securities fell 16250.0% to -$500000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $47.2 million, marking a year-over-year increase of 580000.0%. This contributed to the annual value of $9.5 million for FY2025, which is 1830.04% down from last year.
  • According to the latest figures from Q4 2025, Bio-Techne's Gains from Investment Securities is -$500000.0, which was down 16250.0% from $18.8 million recorded in Q3 2025.
  • Bio-Techne's 5-year Gains from Investment Securities high stood at $122.8 million for Q3 2021, and its period low was -$141.8 million during Q2 2023.
  • In the last 5 years, Bio-Techne's Gains from Investment Securities had a median value of $1.6 million in 2022 and averaged $7.6 million.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first soared by 1744285.71% in 2021, then crashed by 119076.92% in 2023.
  • Quarter analysis of 5 years shows Bio-Techne's Gains from Investment Securities stood at $6.1 million in 2021, then crashed by 62.3% to $2.3 million in 2022, then crashed by 43.48% to $1.3 million in 2023, then crashed by 38.46% to $800000.0 in 2024, then crashed by 162.5% to -$500000.0 in 2025.
  • Its last three reported values are -$500000.0 in Q4 2025, $18.8 million for Q3 2025, and $1.2 million during Q2 2025.